Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis

Hua, Charlotte, Barnetche, Thomas, Combe, Bernard, Morel, Jacques·2014·Arthritis Care & Research
DOI 10.1002/acr.22246

Cited by (289)

Items 201–289 of 289

  1. Musculoskeletal diseases, infections and vaccines: state of the art, research perspectives and educational needs
    Fiona Ecarnot, Jotheeswaran Amuthavalli Thiyagarajan, Mario Barbagallo, Jane Barratt, Stefan N. Constantinescu, Ori Elkayam, Luigi Ferrucci, Mickaël Hiligsmann, Meliha Crnkic Kapetanovic, Francesco Macchia et al. · 2025 · Aging Clinical and Experimental Research
  2. Impfeinstellung, Erwartungen und Impferfahrung von Immunsupprimierten bei COVID-19-Impfungen
    Frank Müller, Stephanie Heinemann, Eva Hummers, Eva Maria Noack, Gloria Heesen, Alexandra Dopfer‐Jablonka, Marie Mikuteit, Jacqueline Niewolik, Sandra Steffens, Dominik Schröder · 2022 · Zeitschrift für Rheumatologie
  3. Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
    Anne Tournadre, Jérémie Sellam, Jacques Morel, D. Jullien, Yoram Bouhnik, Divi Cornec, Valérie Devauchelle‐Pensec, Philippe Goupille, Nicolas Kluger, Estibaliz Lazaro et al. · 2021 · Joint Bone Spine
  4. Reasons for discontinuation of methotrexate in the treatment of rheumatoid arthritis and challenges of methotrexate resumption: a single-center, retrospective study
    Hiroko Nagafuchi, Yutaka Goto, Tomofumi Kiyokawa, Kimito Kawahata · 2022 · Egyptian Rheumatology and Rehabilitation
  5. Specific Cellular and Humoral Response after the Third Dose of Anti-SARS-CoV-2 RNA Vaccine in Patients with Immune-Mediated Rheumatic Diseases on Immunosuppressive Therapy
    Kauzar Mohamed Mohamed, María Paula Álvarez-Hernández, Carlos Jiménez García, Kissy Guevara‐Hoyer, D. Freites, Cristina Martínez Prada, Inés Pérez-Sancristóbal, Benjamín Fernández‐Gutiérrez, Gloria Mato Chaín, María Rodero et al. · 2023 · Biomedicines
  6. Effectiveness and Safety of the COVID-19 Vaccine in Patients with Rheumatoid Arthritis in a Real-World Setting
    María Torres-Rufas, Esther F. Vicente‐Rabaneda, Laura Cardeñoso, Ainhoa Gutierrez, David Andrew Bong, Cristina Valero-Martínez, José M. Serra López-Matencio, Rosario García‐Vicuña, Miguel Ángel González-Gay, Isidoro González‐Álvaro et al. · 2024 · Vaccines
  7. COVID-19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies
    Samuel Whittle, Glen Stewart Hazlewood, Philip Cameron Robinson, Renea V Johnston, Karin S Leder, Vanessa Glennon, Jodie Avery, Liesl Grobler, Rachelle Buchbinder · 2021 · Cochrane Database of Systematic Reviews
  8. Antibody responses to influenza vaccine in patients on biological therapy: Results of RIER cohort study
    Patricia Richi, María Dolores Martín, María Teresa Navío, Laura González-Hombrado, Marina Salido, Jesús Llorente, Israel J. Thuissard, Patricia Alcocer, Carmen María Saa-Requejo, Ana Jiménez-Diaz et al. · 2019 · Medicina Clínica (English Edition)
  9. Efficacy of Pneumococcal Polysaccharide Conjugate Vaccine (13-valent, Adsorbed) in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Genetically Engineered Biologic Drugs (Tocilizumab or Canakinumab): Prospective Cohort Study
    Ekaterina I. Alexeeva, Dariya D. Vankova, T.M. Dvoryakovskaya, Ksenia B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Aleksandra M. Chomakhidze, Т. В. Радыгина, Зубкова Ирина Валентиновна, Н. Е. Ткаченко et al. · 2020 · Вопросы современной педиатрии
  10. Influenza vaccination in chronic inflammatory arthritis undergoing immunosuppressive treatments: temporal trend and factors of adherence
    Luca Quartuccio, Alen Zabotti, Tolinda Gallo, Salvatore De Vita, Francesca Valent · 2020 · Lara D. Veeken
  11. An observational study on the safety of COVID-19 vaccination in patients with myasthenia gravis
    Hengyu Wang, L. Qiu, C.Y. Ou, Ziqi Lin, Z.D. Huang, P. Chen, Qian Ma, Ying Lu, Haitao Ran, Weibin Liu · 2023 · Neurological Sciences
  12. B cells in anti-tRNA synthetase syndrome patients show an activated, interferon-responsive signature
    Erin M. Wilfong, Lindsay E Bass, Leslie J. Crofford, Rachel H. Bonami, The MYSTIC Investigators · 2026 · Frontiers in Immunology
  13. Production of TNF-alpha ex vivo is predictive of an immune response to flu vaccination in a frail elderly population
    Frédéric Bloch, Bénédicte Charmeteau-De Muylder, Michaël G. Tovey, Jean–François Méritet, Corinne Desaint, Odile Launay, Pierre Lebon · 2016 · European Cytokine Network
  14. Serological response to influenza vaccine in patients with autoimmune inflammatory diseases: Results of RIER study
    Patricia Richi, María Dolores Martín, Cristina Andreu Vázquez, Ana Jiménez-Diaz, Martina Steiner, Santiago Muñoz‐Fernández · 2021 · Medicina Clínica (English Edition)
  15. Practical management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI)
    Jacques Morel, Anne Tournadre, Jérémie Sellam, Yoram Bouhnik, Divi Cornec, Valérie Devauchelle‐Pensec, Philippe Dieudé, Philippe Goupille, Nicolas Kluger, Estibaliz Lazaro et al. · 2021 · Joint Bone Spine
  16. Pneumococcal Polysaccharide Vaccines
    John D. Grabenstein, Daniel M. Musher · 2023 · Elsevier eBooks
  17. Patients with juvenile idiopathic arthritis have decreased clonal diversity in the CD8+ T cell repertoire response to influenza vaccination
    Sara E. Sabbagh, Dipica Haribhai, Jill A. Gershan, James W. Verbsky, James J. Nocton, Maryam B. Yassai, Elena N. Naumova, Erin Hammelev, Mahua Dasgupta, Ke Yan et al. · 2024 · Frontiers in Immunology
  18. Antibody responses after sequential vaccination with PCV13 and PPSV23 in patients with moderate to severe plaque psoriasis under immunosuppressive therapy
    Lorena Helmer, Lukas van de Sand, Thea Wojtakowski, Mona Otte, Oliver Witzke, Wiebke Sondermann, Adalbert Krawczyk, Monika Lindemann · 2024 · mBio
  19. Influenza Vaccination Recommendations During Use of Select Immunosuppressants for Psoriasis
    Joyce Y. Kim, Harry Dao · 2020 · Cutis
  20. A 74-year-old female with recurrent infections receiving methotrexate for rheumatoid arthritis
    Sonali Wijetilleka, Sumeet Chander, Mohammed Yousuf Karim · 2019 · Lara D. Veeken
  21. The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study
    Ali Al‐Janabi, Amelle Ra, Zoe Littlewood, Amy Foulkes, Hamish J. A. Hunter, Hector Chinoy, Christopher A Moriarty, Kimme Leanne Hyrich, Jimmy K. Limdi, Zenas Z N Yiu et al. · 2022 · British Journal of Dermatology
  22. The Practice Guideline for Vaccinating Korean Patients With Autoimmune Inflammatory Rheumatic Disease
    Yu Bin Seo, Su‐Jin Moon, Chan Hong Jeon, Joon Young Song, Yoon‐Kyoung Sung, Su Jin Jeong, Ki Tae Kwon, Eu Suk Kim, Jae‐Hoon Kim, Hyoun‐Ah Kim et al. · 2020 · Journal of Rheumatic Diseases
  23. Safety and efficacy of 23-valent polysaccharide pneumococcal vaccine in patients with systemic lupus erythematosus
    Г. М. Тарасова, Boris Sergeyevich Belov, Mariya V. Cherkasova, Elena Aleksandrovna Aseeva, Tatiana Magomedalievna Reshetnyak, Т. В. Попкова, N. M. Kosheleva · 2021 · Modern Rheumatology Journal
  24. COVID vaccine recommendations in dermatologic patients on immunosuppressive agents: Lessons learned from pandemic
    Zeinab Aryanian, Kamran Balighi, Zeinab Mohseni Afshar, Mohammad Hossein Zamanian, Zahra Razavi, Parvaneh Hatami · 2022 · Journal of Cosmetic Dermatology
  25. Correspondence to ‘Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases‘
    Hendrik Schulze‐Koops, Alla Skapenko, Andreas Krause, Klaus Krueger, Hanns‐Martin Lorenz, Philipp Sewerin, Christof Specker, Ulf G. Wagner, Anna Julia Voormann, Ulf Müeller-Ladner et al. · 2020 · Annals of the Rheumatic Diseases
  26. Pausing drugs and spacing vaccines: an open question
    Mia Rodziewicz, Sarah Dyball, Ian N Bruce, Ben Parker · 2021 · The Lancet Rheumatology
  27. Infection risk of targeted synthetic drugs used in immune-mediated inflammatory diseases
    Patricia García, Amaya Arrondo Velasco, María De Miguel · 2022 · Boletín de información farmacoterapéutica de Navarra
  28. Complications virales des biothérapies/thérapies ciblées anti-inflammatoires
    Lionel Piroth, Florian Moretto, Thibaut Sixt, Mathieu Blot · 2025 · La Revue de Médecine Interne
  29. The T-cell response to SARS-CoV- 2 vaccination persists beyond six months in rheumatoid arthritis patients treated with rituximab
    Juliette Marin, P Bourgoin, Noemie Saverna, Celia Cartagena, Pierre Lafforgue, Jean‐Marc Busnel, Nathalie Balandraud · 2025 · Arthritis Research & Therapy
  30. Vaccinating patients with autoimmune diseases
    Ai Li Yeo, Kevin L. Winthrop · 2025 · Joint Bone Spine
  31. Labordiagnostik bei systemischen Autoimmunerkrankungen
    Magnus Diller, Martin Fleck · 2015 · Journal of Laboratory Medicine
  32. Laboratory testing for systemic autoimmune diseases
    Magnus Diller, Martin Fleck · 2016 · Journal of Laboratory Medicine
  33. Bacterial infections in the lungs of patients with systemic autoimmune diseases
    Ilaria Di Cataldo, Alfio Proietto, Irene Coppolino, Mario Francesco Cannavò, Attilio Cotroneo, Federica Lo Bello, Paolo Ruggeri, Ian Michael Adcock, Gaetano Caramori · 2020 · Technical report
  34. Descriptive study of pneumococcal vaccination in cases of inflammatory disease: Analysis of practices
    A. Voignier, S. Skopinski, P. Duffau, E. Ribeiro, Pascal Biscay, J. Constans, P. Mercié · 2022 · Infectious Diseases Now
  35. Vaccinations in Patients with Rheumatic Disease
    Cassandra M. Calabrese · 2022 · Rheumatic Disease Clinics of North America
  36. Single-center experience of COVID-19 vaccine in patients with inflammatory rheumatic disease: Real-life data
    Özlem Pehlivan, Halise Hande Gezer · 2022 · Journal of Surgery and Medicine
  37. Vaccination of pneumococcal infection in patients with systemic lupus erythe matosus and antiphospholipid syndrome: experience of 6 years of use
    Г. М. Тарасова, Boris Sergeyevich Belov, Tatiana Magomedalievna Reshetnyak, Mariya V. Cherkasova · 2023 · Rheumatology Science and Practice
  38. Modern Ideas about Vaccination of Patients with Rheumatic Diseases: the View of ACR Experts
    Boris Sergeyevich Belov, N. V. Muravyevа · 2023 · Antibiot Khimioter = Antibiotics and Chemotherapy
  39. Immunologic Response and Effects of COVID-19 Vaccines in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Ki Hyun Lee, Hyunsue Do, Jun Yong Choi, Yong‐Beom Park, Sinyoung Kim, Sang‐Won Lee, Su Jin Jeong · 2025 · Yonsei Medical Journal
  40. Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia
    Michelle P. Zeller, Donald M. Arnold · 2015 · American Journal of Hematology
  41. When treating rheumatoid arthritis be vigilant for influenza (& pneumonia)
    Arvind Chopra, Vaijayanti Lagoo Joshi · 2017 · The Indian Journal of Medical Research
  42. Is It Time For High Dose Influenza Vaccination In Inflammatory Bowel Diseases?
    Gaurav Syal, Gil Melmed · 2019 · Inflammatory Bowel Diseases
  43. Consenso sobre riesgo de complicaciones infecciosas en pacientes usuarios de medicamentos biológicos seleccionados.Parte II: Guía clínica chilena de Prevención de Infecciones Asociadas al Uso de Terapias Biológicas (PREVITEB)
    Inés Cerón, Cecilia Vizcaya, Pilar Gambra, Marcela Ferrés G, Teresa Bidart H, Tania López, María Paz Acuña, Ana María Álvarez, Marcela Zubieta A, Marcela Rabello et al. · 2019 · Revista chilena de infectología
  44. Immunogenicity, Tolerability, and Clinical Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine in Patients with Systemic Lupus Erythematosus
    Г. М. Тарасова, Boris Sergeyevich Belov, Mariya V. Cherkasova, S. K. Soloviev, Elena Aleksandrovna Aseeva, Tatiana Magomedalievna Reshetnyak, Т. В. Попкова, N. M. Kosheleva · 2020 · Antibiot Khimioter = Antibiotics and Chemotherapy
  45. Ist komplette Immunität gegen Masern bei Patienten mit rheumatischen Erkrankungen ein realistisches Ziel, und wie ist es möglicherweise zu erreichen?
    Jürgen Braun, Uta Kiltz, Ulf Müller‐Ladner · 2020 · Zeitschrift für Rheumatologie
  46. Immunosuppressants, immunomodulators and COVID-19 vaccines: anticipating patient concerns
    Jonathan W. Rick, Alyssa M. Thompson, Jennifer Lin Hsiao, Wilson J. Liao, Vivian Yan Shi · 2021 · Journal of Dermatological Treatment
  47. Antibody response in patients with autoimmune inflammatory rheumatic disease after pneumococcal polysaccharide prime vaccination or revaccination
    SL Rasmussen, L. Strandbygaard, Kurt Fuursted, Kristian Hay Kragholm, Peter Derek Christian Leutscher, Claus Rasmussen · 2022 · Scandinavian Journal of Rheumatology
  48. Antirheumatic biologics in pregnant patients: a call for studies to address the knowledge gap
    Monika Østensen · 2018 · Expert Review of Clinical Immunology
  49. Les vaccinations dans les rhumatismes inflammatoires chroniques de l’adulte : le calendrier vaccinal et les recommandations en cas de traitement de fond classique et biologique
    Jacques Morel, Séverine Guillaume-Czitrom, Auriane Mallick, Jérémie Sellam, Jean Sibilia · 2015 · Revue du Rhumatisme
  50. Échec de la vaccination antipneumococcique en phase d’attaque du traitement des vascularites à ANCA : l’étude Pneumovas pilote 1
    Matthieu Groh, Xavier Puéchal, Benjamin Terrier, Claire Le Jeunne, Frédéric Batteux, Odile Launay · 2017 · Revue du Rhumatisme
  51. Pneumococcal vaccination in inflammatory rheumatic disease. Antibody response and protection against infections.
    Johanna Nagel · 2018 · Lund University Publications (Lund University)
  52. Traitements biologiques des rhumatismes inflammatoires chroniques : résultats cliniques
    André Kahan · 2018 · Bulletin de l Académie Nationale de Médecine
  53. Vaccines in Rheumatic Diseases
    Carlos Pineda, Carina Soto-Fajardo, Julio Granados · 2019 · Springer eBooks
  54. Les bronchectasies dans la polyarthrite rhumatoïde : évaluation clinique
    Ana Catarina Duarte, Joanna C. Porter, Maria José Leandro · 2020 · Revue du Rhumatisme
  55. COVID-19 bei Kindern und Jugendlichen
    Susanna Felsenstein, Christian Michael Hedrich · 2020 · Arthritis und Rheuma
  56. Les vaccinations dans les rhumatismes inflammatoires chroniques de l'adulte
    Jacques Morel · 2018 · Elsevier eBooks
  57. Vaccination Recommendations in Patients with Autoimmune inflammatory Rheumatic Diseases
    Yasser Abed El-Hamid, M.E. Yousef, S.M. Rashad · 2021 · Benha Journal of Applied Sciences
  58. Anti-inflammatory drugs and immunogenicity of vaccines in patients with rheumatic diseases
    Boris Sergeyevich Belov, N. V. Muravyevа, М. М. Баранова · 2021 · Meditsinskiy sovet = Medical Council
  59. En quoi la Covid-19 concerne la prise en charge des rhumatismes inflammatoires ? Place de la vaccination selon les cas
    Jacques Morel, Christophe Richez · 2021 · Revue du Rhumatisme Monographies
  60. Seroprevalence of SARS-CoV-2 IgG Antibodies After the Second BNT162b2 mRNA Vaccine in Japanese Kidney Transplant Recipients
    Tomoko Hamaya, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hirotake Kodama, Takeshi Fujita, Reiichi Murakami, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto et al. · 2021 · Research Square
  61. Faculty Opinions recommendation of Mapping Host-Related Correlates of Influenza Vaccine-Induced Immune Response: An Umbrella Review of the Available Systematic Reviews and Meta-Analyses.
    Graham Pawelec · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  62. Réponse sérologique après vaccination contre le coronavirus chez les patients atteints de rhumatisme inflammatoire chronique traités par DMARDs : étude de cohorte et revue systématique avec méta-analyse
    Maxime Auroux, Benjamin Laurent, Baptiste Coste, Emmanuel Massy, Alexandre Mercier, I. Durieu, Cyrille B. Confavreux, Jean‐Christophe Lega, Sabine Mainbourg, Fabienne Coury · 2022 · Revue du Rhumatisme
  63. Prévention des infections et vaccination dans les rhumatismes inflammatoires chroniques
    Jacques Morel · 2022 · Revue du Rhumatisme Monographies
  64. Efficacy of coronavirus disease 2019 vaccines in patients with rheumatic diseases
    Fatih Taştekin, Meltem Isikgoz Tasbakan, Candan Çiçek, Mehmet Soylu, Figen Yargucu Zihni · 2023 · Archives of Rheumatology
  65. Preventative Care in Scleroderma
    Leonardo Martin Calderon, Janet Elizabeth Pope, Ami A. Shah, Robyn T. Domsic · 2023 · Rheumatic Disease Clinics of North America
  66. Cellular Immune Response Persistence among COVID-19 Vaccinated Rheumatoid Arthritis Patients Treated by Rituximab
    Juliette Marin, P Bourgoin, Noemie Saverna, Celia Cartagena García, Pierre Lafforgue, Jean‐Marc Busnel, Nathalie Balandraud · 2023 · SSRN Electronic Journal
  67. Understanding patient perspectives on vaccine decision making in adults with autoimmune bullous diseases: a qualitative study
    Alice J. Tan, Marjorie Archila, John S. Barbieri, Arash Mostaghimi, Aaron M. Scherer, Lourdes Maria Perez-Chada, Maryam M. Asgari, Joel M. Gelfand, Megan H. Noe · 2024 · Archives of Dermatological Research
  68. Indikationen zur Unterbrechung von rheumatologischen Basistherapien
    Rainer Hintenberger · 2024 · rheuma plus
  69. Methotrexate and immunogenicity of vaccines in patients with rheumatic diseases
    Boris Sergeyevich Belov, N. V. Muravyevа, Evgeny Lvovich Nasonov · 2024 · Rheumatology Science and Practice
  70. Vaccinations in Patients with Autoimmune Diseases
    Isa Seida, Naim Mahroum · 2024
  71. Review of Pemphigus Vulgaris Management
    Bahar Bahrani · 2025 · Canadian dermatology today.
  72. Additional file 4 of Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response
    Filippini, Federica, Mauro Giacomelli, Chiara Bazzani, Micaela Fredi, Paolo Semeraro, Tomasi, Cesare, Franco Franceschini, Arnaldo Caruso, Cavazzana, Ilaria, Cinzia Giagulli · 2024 · Figshare
  73. Additional file 2 of Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response
    Filippini, Federica, Mauro Giacomelli, Chiara Bazzani, Micaela Fredi, Paolo Semeraro, Tomasi, Cesare, Franco Franceschini, Arnaldo Caruso, Cavazzana, Ilaria, Cinzia Giagulli · 2024 · Figshare
  74. Additional file 7 of Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response
    Filippini, Federica, Mauro Giacomelli, Chiara Bazzani, Micaela Fredi, Paolo Semeraro, Tomasi, Cesare, Franco Franceschini, Arnaldo Caruso, Cavazzana, Ilaria, Cinzia Giagulli · 2024 · Figshare
  75. Additional file 5 of Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response
    Filippini, Federica, Mauro Giacomelli, Chiara Bazzani, Micaela Fredi, Paolo Semeraro, Tomasi, Cesare, Franco Franceschini, Arnaldo Caruso, Cavazzana, Ilaria, Cinzia Giagulli · 2024 · Figshare
  76. Additional file 1 of SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study
    Alexandra Dopfer‐Jablonka, Steffens, Sandra, Frank Müller, Marie Mikuteit, Jacqueline Niewolik, Anne Cossmann, Metodi V. Stankov, Behrens, Georg M. N., Eva Hummers, Gloria Heesen et al. · 2022 · Figshare
  77. Additional file 6 of Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response
    Filippini, Federica, Mauro Giacomelli, Chiara Bazzani, Micaela Fredi, Paolo Semeraro, Tomasi, Cesare, Franco Franceschini, Arnaldo Caruso, Cavazzana, Ilaria, Cinzia Giagulli · 2024 · Figshare
  78. Additional file 9 of Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response
    Filippini, Federica, Mauro Giacomelli, Chiara Bazzani, Micaela Fredi, Paolo Semeraro, Tomasi, Cesare, Franco Franceschini, Arnaldo Caruso, Cavazzana, Ilaria, Cinzia Giagulli · 2024 · Figshare
  79. Additional file 8 of Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response
    Filippini, Federica, Mauro Giacomelli, Chiara Bazzani, Micaela Fredi, Paolo Semeraro, Tomasi, Cesare, Franco Franceschini, Arnaldo Caruso, Cavazzana, Ilaria, Cinzia Giagulli · 2024 · Figshare
  80. Additional file 1 of Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response
    Filippini, Federica, Mauro Giacomelli, Chiara Bazzani, Micaela Fredi, Paolo Semeraro, Tomasi, Cesare, Franco Franceschini, Arnaldo Caruso, Cavazzana, Ilaria, Cinzia Giagulli · 2024 · Figshare
  81. Additional file 3 of Efficacy of COVID-19 mRNA vaccination in patients with autoimmune disorders: humoral and cellular immune response
    Filippini, Federica, Mauro Giacomelli, Chiara Bazzani, Micaela Fredi, Paolo Semeraro, Tomasi, Cesare, Franco Franceschini, Arnaldo Caruso, Cavazzana, Ilaria, Cinzia Giagulli · 2024 · Figshare
  82. Brazilian Society of Rheumatology – 2025 recommendations on vaccination in immune-mediated rheumatic diseases
    Gecilmara Salviato Pileggi, Vítor Alves Cruz, Ana Cristina de Medeiros Ribeiro, Ana Karla Guedes de Melo, André Gustavo Cunha Trolese, Anna Carolina Faria Moreira Gomes Tavares, Cristiano A. F. Zerbini, Erika Biegelmeyer, Flávia Maria Matos Melo Campos Peixoto, Gilda Aparecida Ferreira et al. · 2026 · Revista Brasileira de Reumatologia
  83. Recombinant Herpes Zoster Vaccine in Immunosuppressed Rheumatology Patients: Real-World Safety Data from a Prospective Cohort Study in Saudi Arabia
    Khawla K. Alghanim, Raed Mubarek Alqahtani, Darren Alghadhiyah, Khalid N. Alharbi, Hatoon M. Aljuaid, Arulanantham Z. Jebakumar, Hesham W. Elsayed · 2026 · Annals of Rheumatology and Autoimmunity
  84. Mise au point de modèles animaux pour étudier la physiopathologie de la polyarthrite rhumatoïde et le rôle du méthotrexate dans la tolérisation
    Samuel Bitoun · 2018
  85. Vaccination for Patients With Immunosuppression and Altered Immunity: A Workgroup Report from the AAAAI Adverse Reactions to Drugs, Biologics, and Vaccines Committee and the Autoimmunity and Altered Immune Response Committee
    Mildred Kwan, Blanka M. Kaplan, Krista Shaw, Veronica C Alix, Vishaka R Hatcher, Isma Shah, Donald S. Levy, Maria Shabih, Allison Eaddy Norton, Aarti Pandya et al. · 2026 · The Journal of Allergy and Clinical Immunology In Practice
  86. Cellular immune response to pneumococcal vaccination in patients with rheumatoid arthritis receiving methotrexate and rituximab (Literature review)
    Anna Dmitrievna Shmitko, А. А. Тарасова, Б Ц Батожаргалова, М. П. Костинов · 2026 · Pacific Medical Journal
  87. Vaccination in Juvenile Idiopathic Inflammatory Myopathies: Current Evidence-Based Recommendations
    V. Cynthia Sherin, Neya Aparajitha Saravanarajan, S Kiruthika, Jessica A Sharon, Balamurugan Durai, Jenefer Pamalene Richard, Rajeev Zachariah Kompithra · 2026 · RESEARCH REVIEW International Journal of Multidisciplinary
  88. Effect of Temporary Methotrexate Discontinuation on Vaccine Immunogenicity and Disease Flare in Rheumatoid Arthritis: A Systematic Review
    Ayesha Tahir, Ammara Iftikhar, Kashaw Kumar, Yusra Nawaz, Pakeeza Fatima, Muhammad Saeed, Shaheer Suhail Sarwar, Fatima Khalid, Ayesha Javaid, Bushra Akhtar et al. · 2026 · Annals of Pharmacotherapy
  89. Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus
    Michael Diamond · 2025 · ImmPort